• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS INC. NEUROSTAR; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS INC. NEUROSTAR; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Headache (1880)
Event Date 05/01/2021
Event Type  Injury  
Event Description
I get severe headaches at least 4 days per week after getting tms treatment.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
Manufacturer (Section D)
NEURONETICS INC.
MDR Report Key15094163
MDR Text Key296570865
Report NumberMW5111076
Device Sequence Number1
Product Code OBP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 07/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
GABAPENTIN; HALDOL; LEXAPRO; ORAL BIRTH CONTROL; WELLBUTRIN; XANAX
Patient Outcome(s) Disability;
Patient Age31 YR
Patient SexFemale
Patient Weight63 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-